[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335715-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335715-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","integrated-multi-omics-analysis-reveals-clinical-significance-of-hepatocyte-nuclear-factor-1-in-tumor-immune-microenvironment-immunotherapy-and-prognostic-prediction-for-colon-adenocarcinoma","Integrated multi-omics analysis reveals clinical significance of hepatocyte nuclear factor-1β in tumor immune microenvironment, immunotherapy and prognostic prediction for colon adenocarcinoma","","Background research highlights hepatocyte nuclear factor 1β (HNF1B) as an important regulator in organ development and cancer, including colon cancer linked to shifted-code mutations. The mechanisms by which HNF1B shapes cancer immunotherapy response and the tumor immune microenvironment remain unclear. This study analyzes how HNF1B affects colon cancer immunotherapy, integrating bioinformatics discovery with external database support and experimental validation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/integrated-multi-omics-analysis-reveals-clinical-significance-of-hepatocyte-nuclear-factor-1-in-tumor-immune-microenvironment-immunotherapy-and-prognostic-prediction-for-colon-adenocarcinoma/335715/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/integrated-multi-omics-analysis-reveals-clinical-significance-of-hepatocyte-nuclear-factor-1-in-tumor-immune-microenvironment-immunotherapy-and-prognostic-prediction-for-colon-adenocarcinoma/335715.png","ImageObject",300,407,{"name":42,"@type":43},"Theodora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does HNF1B play in colon cancer immunotherapy according to this study?","Question",{"text":63,"@type":64},"The study investigates how HNF1B influences immunotherapy outcomes and the immune microenvironment in colon cancer, clarifying its immuno-related function.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which datasets and sample size were used to analyze colon adenocarcinoma?",{"text":68,"@type":64},"The analysis used 1,374 colon adenocarcinoma samples from TCGA and GEO datasets.",{"name":70,"@type":61,"acceptedAnswer":71},"How is HNF1B related to the tumor immune microenvironment and treatment response?",{"text":72,"@type":64},"HNF1B expression is linked to prognosis and associations with macrophage infiltration, immune checkpoints, and signaling pathways, with validation indicating that low HNF1B expression benefits less from immunotherapy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335715,1790241058,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","Cancer Immunology, Immunotherapy (2025) 74:38 [https://doi.org/10.1007/s00262-024-03870-8](https://doi.org/10.1007/s00262-024-03870-8)  \nIntegrated multi‑omics analysis reveals clinical significance of hepatocyte nuclear factor‑1β in tumor immune microenvironment, immunotherapy and prognostic prediction for colon adenocarcinoma  \nFushan Gao1,3 · Wenlin Gong1,2,3 · Haihua He1,3 · Zhen Zhang1,3 · Hongcai Yang2,5 · Fei Shao1,3,4 · Yibo Gao1,3,4,6 · Jie He1,4  \nReceived: 31 August 2024 / Accepted: 29 October 2024 / Published online: 30 December 2024 © The Author(s) 2024  \nAbstract  \nBackground Research has consistently highlighted the key role of hepatocyte nuclear factor 1β (HNF1B) in organ development and cancer, including its involvement in colon cancer via shifted-code mutations. However, the specific effects of HNF1B on cancer immunotherapy and the immune microenvironment are not fully understood. This study investigated the impact of HNF1B on colon cancer immunotherapy in depth.  \nMethods We analyzed 1,374 colon adenocarcinoma samples from the TCGA and GEO datasets. Our approach involved bioinformatics to uncover how HNF1B influences immunotherapy and the immune microenvironment, with corroboration from external databases and experimental validation.  \nResults HNF1B was expressed at low levels in colon adenocarcinoma and was linked to patient prognosis. CIBERSORT, TIME, and GSVA analyses revealed that HNF1B was associated with macrophage infiltration, immune checkpoints, and signaling pathways. Drug prediction suggested a negative relationship between HNF1B and EGFR-targeted therapies, implying potential resistance. Validation with external cohorts confirmed that patients with low HNF1B expression experienced less benefit from immunotherapy.  \nConclusion This study clarifies the role of HNF1B in the treatment of colon adenocarcinoma. This study provides a foundation for further in-depth mechanistic studies and proposes new directions for optimizing immunotherapy strategies for colon adenocarcinoma.  \nKeywords Colorectal adenocarcinoma · Immunotherapy · Hepatocyte nuclear factor-1β · Tumor microenvironment · Immune checkpoint blockade  \nIntroduction  \nThe hepatocyte nuclear factor (HNF) family comprises a group of transcription factors that play pivotal roles in regulating liver function and a range of metabolic processes [1] . HNF3α (FOXA1) has been demonstrated to exert either tumor-suppressive or oncogenic effects in breast and prostate cancer, contingent on the cellular context and mutation status [2–5] . HNF1α and HNF1B are exemplars of the homodimer transcription factor class and exhibit analogous domains [6] . HNF1α is abundantly expressed in  \nFushan Gao and Wenlin Gong have contributed equally to this work and are co-first authors.  \nExtended author information available on the last page of the article  \nhepatic tissues, where it regulates metabolic genes, including glycogen synthase and glucose-6-phosphatase. The oncogenic role ofHNF1B has been documented in numerous tumor types, including prostate, lung, and renal cell carcinomas. In terms of its mechanism of action, HNF1B can exhibit either oncogenic or tumor-suppressive effects, depending on the specific type of cancer in question. For example, in advanced prostate cancer, HNF1B interacts with EZH2 to regulate SLUG gene expression and the epithelial‒mesenchymal transition (EMT) process [7] . HNF1B has been recognized as a gene associated with susceptibility specific to subtypes of ovarian cancer via DNA methylation sequencing and subtype expression profiling [8] . In breast cancer, the methylation of homeobox genes, including HOXB13 and HNF1B, is markedly more pronounced than that in normal samples [9] . Pancreatic  \nintraepithelial neoplasia development and progression are observed in HNF1B mutants, particularly when HNF1B is combined with KRAS [10] .  \nStudies have reported that the upregulation of HNF1Bin ovarian clear cell carcinoma (OCCC) activates the STAT3","cbCaiuEisbpYWIHl","https://ap.wps.com/l/cbCaiuEisbpYWIHl","pdf",5688923,17,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What role does HNF1B play in colon cancer immunotherapy according to this study?\",\"answer\":\"The study investigates how HNF1B influences immunotherapy outcomes and the immune microenvironment in colon cancer, clarifying its immuno-related function.\"},{\"question\":\"Which datasets and sample size were used to analyze colon adenocarcinoma?\",\"answer\":\"The analysis used 1,374 colon adenocarcinoma samples from TCGA and GEO datasets.\"},{\"question\":\"How is HNF1B related to the tumor immune microenvironment and treatment response?\",\"answer\":\"HNF1B expression is linked to prognosis and associations with macrophage infiltration, immune checkpoints, and signaling pathways, with validation indicating that low HNF1B expression benefits less from immunotherapy.\"}]","Integrated multi-omics analysis reveals clinical significance of hepatocyte nuclear factor-1β in tumor immune microenvironment, immunotherapy and prognostic prediction for colon adenocarcinoma | PDF",1790012058,43]